Study looks at safety, effectiveness of generics for treating depression
Researchers at the School of Medicine are studying the quality, effectiveness and safety of generic drugs used to treat depression. The research, supported by the U.S. Food and Drug Administration, is the only study of its kind in the nation. Pictured is the study’s principal investigator, Evan D. Kharasch, MD, PhD.